Please use this identifier to cite or link to this item: https://covid-19.conacyt.mx/jspui/handle/1000/720
Breakthrough: Chloroquine phosphate has shown apparent efficacy in treatment of COVID-19 associated pneumonia in clinical studies
Gao, J
Tian, Z
Yang, X
Acceso Abierto
Atribución-NoComercial-SinDerivadas
The coronavirus disease 2019 (COVID-19) virus is spreading rapidly, and scientists are endeavoring to discover drugs for its efficacious treatment in China. Chloroquine phosphate, an old drug for treatment of malaria, is shown to have apparent efficacy and acceptable safety against COVID-19 associated pneumonia in multicenter clinical trials conducted in China. The drug is recommended to be included in the next version of the Guidelines for the Prevention, Diagnosis, and Treatment of Pneumonia Caused by COVID-19 issued by the National Health Commission of the People's Republic of China for treatment of COVID-19 infection in larger populations in the future.
BioScience Trends
2020
Preimpreso
https://coronavirus.1science.com/item/e6cfade06d54a31cbbb918ac6d1f734ab96170cd
Inglés
VIRUS RESPIRATORIOS
Appears in Collections:Artículos científicos

Upload archives


File SizeFormat 
101551.pdf199.71 kBAdobe PDFView/Open